[Skip to Content]
[Skip to Content Landing]
July 30, 1973


JAMA. 1973;225(5):517. doi:10.1001/jama.1973.03220320047014

Approximately one quarter of a million American physicians are familiar with the first edition of AMA Drug Evaluations (AMA-DE), the American Medical Association's comprehensive treatise on drugs. This book, released in 1971, has been widely acclaimed for its forthright, scientific approach in evaluating therapeutic agents. A revised second edition will appear early in September 1973.

The second edition of AMA-DE will describe approximately 1,200 drugs, both single-entity compounds and mixtures; this coverage embraces about 95% of the drugs used in medical practice. Prepared by the AMA Department of Drugs with the advice of more than 300 consultants, AMA-DE presents considered judgments on the comparative efficacy and safety of drugs. As an organization independent of both the Food and Drug Administration (FDA) and the pharmaceutical industry, the American Medical Association is in a unique position to provide unbiased value judgments on drugs. Indeed, many of the judgments on effectiveness found in